Insider Transactions Reported by 20 Insiders of MAXCYTE, INC.

Symbol
MXCT on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

MAXCYTE, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Casdin Partners Master Fund, L.P. 10%+ Owner $45,300,000 03 Oct 2022
Art Mandell Director $1,940,066 11 Jun 2024
Douglas Doerfler President and CEO, Director $1,509,382 04 Dec 2023
Stanley C. Erck Director $546,585 +$137,220 +34% 13 Aug 2025
J. STARK THOMPSON PHD Director $502,459 09 Aug 2021
John Joseph Johnston Director $407,360 -$13,935 -3.3% 18 Jun 2025
DOUGLAS RICHARD Director $320,040 +$111,040 +53% 13 Aug 2025
Maher Masoud President and CEO, Director $240,135 +$102,915 +75% 13 Aug 2025
Douglas J. Swirsky Chief Financial Officer $208,736 +$42,439 +26% 13 Aug 2025
David Sandoval General Counsel $204,171 -$21,394 -9.5% 18 Mar 2025
William W. Brooke Director $194,633 +$64,500 +50% 13 Aug 2025
Cynthia Collins Director $192,515 18 Jun 2025
Ali Soleymannezhad Chief Commercial Officer $188,974 -$3,850 -2% 18 Mar 2025
PATRICK J. BALTHROP Director $120,373 18 Jun 2025
Yasir B. Al-Wakeel Director $120,373 18 Jun 2025
Thomas M. Ross Evp, Global Sales $109,025 01 Aug 2024
Rekha Hemrajani Director $83,555 -$22,378 -21% 25 Jun 2025
Amanda Louise Murphy Chief Financial Officer 25 Mar 2022
Ron Holtz Chief Financial Officer 20 Mar 2023
Cenk Sumen Chief Scientific Officer 11 Apr 2022

Recent Insider Transactions by Companies or Individuals for MAXCYTE, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.